Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trabectedin in Metastatic Breast Cancer Subpopulations
NCT00580112Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Jun 2007
- Primary completion
- Aug 2011
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of trabectedin in breast cancer, sponsored by Johnson & Johnson. Started Jun 2007; status: completed.
02
Drugs
trabectedin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00580112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00580112.